No Data
The Iran conflict sparks a PGMEA supply crisis, another 'chokepoint' moment for global AI chips?
More than 40% of Japan's naphtha imports have been disrupted, triggering a supply crisis for the semiconductor lithography solvent propylene glycol monomethyl ether acetate (PGMEA). Leading chemical company Shin-Etsu Chemical has withdrawn its earnings forecast, while Samsung and SK Hynix have received warnings of supply disruptions. The transition to alternative materials is expected to take up to a year. Although there may be several months and dozens of production steps between the naphtha supply disruption and the shutdown of semiconductor production lines, analysts warn that the potential downside risks have been significantly underestimated.
Yida Co., Ltd.: First Quarter Report for 2026
Yida Co., Ltd.: 2025 Annual Report
Yida Co., Ltd.: Summary of the 2025 Annual Report
Yida Shares (300721.SZ) reported its first-quarter performance, turning a profit of 4.3096 million yuan after reversing losses.
Yida Co., Ltd. (300721.SZ) released its Q1 2026 report, showing operating revenue of 548 million yuan, a year-on-year increase of 64.92%. Net profit attributable to shareholders of the listed company amounted to 4.31 million yuan. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.72 million yuan. Basic earnings per share were 0.0261 yuan.
Yida Co., Ltd. reported revenue of 1.596 billion yuan in 2025, with a net loss attributable to shareholders of 109 million yuan. Traditional alcohol ether products accounted for over 80% of total revenue.
In 2025, the company's revenue reached 1.596 billion yuan, representing a year-on-year decline of 9.74%. The net profit attributable to shareholders recorded a loss of 109 million yuan, deteriorating more than 12-fold compared to the previous year. The gross profit margin was merely 0.11%, reflecting a year-on-year drop of 10.48 percentage points. Traditional alcohol ether products accounted for 80.05% of total revenue, indicating high concentration in core operations but facing significant profitability pressures as price reductions far exceeded cost cuts. Both R&D and sales expenses contracted simultaneously, yet failed to reverse the operating loss situation.